 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
,
,¶,¶,#,¶,#
*Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA; Department of Medicine, School of Medicine, Tulane University, New Orleans, LA; Departments of Epidemiology, Biostatistics, ¶Medicine, #Health Policy and Management, The Bloomberg School of Hygiene and Public Health and Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Correspondence to Dr. Paul Muntner, Department of Epidemiology, Tulane University SPHTM, 1430 Tulane Avenue, SL-18, New Orleans, LA 70112. Phone: 504-988-1047; Fax: 504-988-1568;
ABSTRACT. This study examined the extent to which the greater than threefold increase in number of treated end-stage renal disease (ESRD) cases between 1978 and 1991 is explained by increases in the prevalence of diabetes, myocardial infarction (MI) and stroke survivors, and US population size. The change in number of persons in the United States with diabetes, a history of MI or stroke, and without these conditions was estimated for 1978 and 1991 using the Second and Third National Health and Nutrition Examination Surveys. The treated ESRD incidence rate and the increase in ESRD treatment attributable to each of these populations were calculated using these estimates and data from the United States Renal Data System. In the United States, there were an estimated 4.3 and 1.2 million more persons with diabetes and a history of MI or stroke, respectively, 22.7 million more persons without these conditions, and 36,881 more incident treated ESRD cases in 1991 compared with 1978. In 1991, treated ESRD incidence rates among persons with diabetes, a history of MI or stroke, and without these conditions were 2567, 1463, and 153 cases per million person-years, respectively. In 1991, 10,183 cases of the additional 36,881 treated ESRD cases (27.6%) resulted from the higher prevalence of diabetes; 1775 (4.8%) from increased MI and stroke survival; and 2904 (7.9%) resulted from growth of the US population without these conditions. The increasing number of treated ESRD cases in the United States is partly explained by the increase in diabetes prevalence and US population growth but only minimally by MI and stroke survival. E-mail: pmuntner@jhsph.edu
This article has been cited by other articles:
 |
|
 |
|
  S. V. Jassal MB BCh MD, L. Trpeski MPH MD, N. Zhu MD, S. Fenton MD, and B. Hemmelgarn PhD MD Changes in survival among elderly patients initiating dialysis from 1990 to 1999 Can. Med. Assoc. J., October 23, 2007; 177(9): 1033 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Jager and P. C. W. van Dijk Has the rise in the incidence of renal replacement therapy in developed countries come to an end? Nephrol. Dial. Transplant., March 1, 2007; 22(3): 678 - 680. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kurella, K. E. Covinsky, A. J. Collins, and G. M. Chertow Octogenarians and Nonagenarians Starting Dialysis in the United States Ann Intern Med, February 6, 2007; 146(3): 177 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-y. Hsu, A. S. Go, C. E. McCulloch, J. Darbinian, and C. Iribarren Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kiberd The Chronic Kidney Disease Epidemic: Stepping Back and Looking Forward J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2967 - 2973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The ESRD Incidence Study Group Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002 Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2178 - 2183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stengel and C. Couchoud Chronic Kidney Disease Prevalence and Treated End-Stage Renal Disease Incidence: A Complex Relationship J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2094 - 2096. [Full Text] [PDF]
|
|
|
|
|
|
W. M. McClellan The epidemic of renal disease--what drives it and what can be done? Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1461 - 1464. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Muntner, K. B. DeSalvo, R. P. Wildman, P. Raggi, J. He, and P. K. Whelton Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke Am. J. Epidemiol., May 15, 2006; 163(10): 913 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hegarty, R.J. Middleton, M. Krebs, H. Hussain, C. Cheung, T. Ledson, A.J. Hutchison, P.A. Kalra, H.C. Rayner, P.E. Stevens, et al. Severe acute renal failure in adults: place of care, incidence and outcomes QJM, September 1, 2005; 98(9): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508. [Full Text] [PDF]
|
|
|
|
|
|
J. Coresh, D. Byrd-Holt, B. C. Astor, J. P. Briggs, P. W. Eggers, D. A. Lacher, and T. H. Hostetter Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000 J. Am. Soc. Nephrol., January 1, 2005; 16(1): 180 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-y. Hsu, E. Vittinghoff, F. Lin, and M. G. Shlipak The Incidence of End-Stage Renal Disease Is Increasing Faster than the Prevalence of Chronic Renal Insufficiency Ann Intern Med, July 20, 2004; 141(2): 95 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. McClellan, R. D. Langston, and R. Presley Medicare Patients with Cardiovascular Disease Have a High Prevalence of Chronic Kidney Disease and a High Rate of Progression to End-Stage Renal Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1912 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ritz and W. M. McClellan Overview: Increased Cardiovascular Risk in Patients with Minor Renal Dysfunction: An Emerging Issue with Far-Reaching Consequences J. Am. Soc. Nephrol., March 1, 2004; 15(3): 513 - 516. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
